Fed's Surprise Rate-Cut Plan Sparks Hope for Biotech Market Rebound in 2024

1 min read
Source: Endpoints News
Fed's Surprise Rate-Cut Plan Sparks Hope for Biotech Market Rebound in 2024
Photo: Endpoints News
TL;DR

The Federal Reserve's surprise announcement of plans to cut interest rates three times next year has sparked hope for a rebound in the biotech market. High interest rates have hindered fundraising and IPOs in the sector since early 2022, but the Fed's decision has brought optimism to a struggling industry plagued by layoffs and falling valuations.

Share this article

Want the full story? Read the original reporting

Read on Endpoints News